來源:[1] Rybelsus更新的歐盟標籤能否推動諾和諾德的新的增長潛力? (https://finance.yahoo.com/news/rybelsus-updat ...)[2] 歐盟批准Rybelsus心臟益處標籤後,諾和諾德股價上漲 - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)[3] 諾和諾德(CPSE:NOVO B)在Rybelsus贏得歐盟心血管標籤更新後上漲5.2%——牛市案例改變了嗎? - Simply Wall St (https://vertexaisearch.cloud.google.com/groun ...)